Enveric Biosciences Inc. (ENVB)
ENVB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.40
-4.76% on the day
Market cap
$6.3M
Nano cap
Revenue
No annual revenue filed since the period ending 2019-12-31
Net income
No annual revenue filed since the period ending 2019-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ENVB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000890821 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2019-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-09 |
| Latest annual report | 10-K | 2026-03-27 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-08-14 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TRAW | Traws Pharma Inc. | $0.4101 | -1.42% | $6.3M |
| BGMS | Bio Green Med Solution Inc. | $0.9199 | -7.08% | $6.1M |
| FBLG | FibroBiologics Inc. | $0.9599 | -4.01% | $6.5M |
| ALZN | Alzamend Neuro Inc. | $1.35 | +3.05% | $6.5M |
| IMNN | Imunon Inc. | $1.07 | 0.00% | $6.0M |
| NRSN | NeuroSense Therapeutics Ltd. | $3.49 | +0.29% | $6.6M |
| CANF | Can-Fite Biopharma Ltd | $1.95 | 0.00% | $5.9M |
| LEXX | Lexaria Bioscience Corp. | $2.80 | -14.37% | $5.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier